There were significant differences in mean age and the proportions of patients with a medical history of ischemic heart disease and hypertension, and treatment with antidiabetic drugs and lipid-lowering drugs among the five groups of DPP-4 inhibitor users. This evidence concerns the gene DPP4 and coronary artery disorder.